Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStopping Wegovy without regaining weight is possible, but it requires a deliberate plan. Semaglutide suppresses appetite and slows gastric emptying while you take it; when treatment ends, those effects fade and hunger signals return. Research is clear that people who taper carefully, build sustainable habits beforehand, and keep close clinical oversight give themselves the best chance of holding their results. This is a prescription medicine and the safest way to stop it is always under guidance from the prescriber who approved it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first step happens before you skip a single injection. Talk to whoever holds your prescription. Stopping abruptly (missing a pen without a plan) removes semaglutide's appetite-suppressing effect faster than a gradual dose reduction, and leaves you with no strategy in place for the weeks ahead. Your prescriber can review whether a step-down to a lower dose first makes clinical sense for you, and can flag any contraindications or timing issues that matter.
There is no standard NHS taper schedule published for stopping Wegovy in healthy adults, partly because the NHS patient information for semaglutide is clear that stopping should always be discussed with a healthcare professional. What a clinical review does is personalise that conversation to your history, your current dose, and your goals. If you are mid-titration, the considerations differ from stopping at the full 2.4mg maintenance dose.
Timing matters more than people expect. If you are planning to stop around a holiday, a work deadline, or a busy stretch, factor that in, starting a new eating structure during a chaotic fortnight is harder than it needs to be. Build the transition around a period when you have some routine.
Semaglutide creates a window. Hunger is quieter, portions are smaller by default, and it is easier to practise eating patterns you want to keep. The research cited in NICE's appraisal of semaglutide (TA875) notes that the medicine is intended to work alongside a reduced-calorie diet and increased physical activity, not instead of them. That pairing matters even more once you stop.
In practical terms, this means using the final weeks or months of treatment to lock in the habits you are relying on afterwards: consistent meal timing, adequate protein at each meal to support satiety and muscle, and a fibre intake that slows digestion naturally. These are not dramatic changes; they are the structural ones that persist when the pharmacological appetite suppression is gone.
Strength training is worth singling out. During rapid weight loss (with or without a GLP-1 medicine) some lean muscle is lost alongside fat. Preserving or rebuilding that muscle raises resting calorie requirements, which matters for long-term weight maintenance. A physiotherapist or qualified fitness professional can help you build a programme that suits your current fitness level. Your prescriber can advise on how much physical activity is appropriate for you specifically.
Hunger does not flood back the moment you stop. For most people it returns gradually over several weeks as semaglutide clears the body. What many people describe is not a sudden urge to overeat but a return of food thoughts and a reduction in early fullness. Recognising this as a physiological change (the medicine's effect fading, not a failure of willpower) helps you respond to it calmly and with the habits from Step 2 already in place.
Some weight fluctuation in the first few weeks after stopping is normal and partly reflects fluid shifts rather than fat change. If you are already thinking through whether you can come off Wegovy without gaining weight, it is worth separating short-term variation from a sustained upward trend before drawing conclusions. Keep the same weigh-in routine you used during treatment (same day, same time, same conditions) so the numbers are comparable.
If appetite returns more aggressively than expected, or you find the habits harder to maintain than planned, get back in touch with your prescriber promptly. If you noticed your Wegovy weight loss slowing down before you stopped, that context is worth sharing with your prescriber when discussing next steps. For some people, a structured wean rather than a full stop turns out to be the right approach. That is a clinical decision, not a personal one.
Obesity is a chronic condition. Stopping Wegovy does not mean the underlying biology has changed permanently, and there is no shame in needing ongoing support. The question of whether to restart, switch to a different treatment, or continue managing through lifestyle alone is one your clinical team is well placed to help you think through, it depends on how much weight you have maintained, your health markers, and your own goals.
For context on what else is available, the weight-loss treatments page sets out the licensed options and how the consultation process works. If you stopped Wegovy because of side effects rather than reaching your goal, it is worth discussing whether tirzepatide (Mounjaro) (a dual-receptor medicine with a different mechanism) might suit you better. A prescriber can compare the profiles with you. If you would like practical guidance on how to lose weight without relying on Wegovy, our cost guide explains what a full private prescription includes alongside those alternatives. Our Wegovy cost guide explains what a full private prescription includes.
Some people manage well after stopping. Others find that weight gradually returns and decide treatment is right for them long-term. Both outcomes are legitimate, and both deserve clinical support rather than guesswork. Our clinical team reviews every consultation personally, the same-day assessment is for returning patients reconsidering treatment just as much as it is for first-timers. If you have questions before you decide anything, the FAQs page covers many of the practicalities.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.